{"id":"tp-58323","type":"article-newspaper","title":"Prelude Therapeutics Posts $5.6 Million in Q3 Revenue as Net Loss Narrows","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/58323","datePublished":"2026-11-16T12:36:57.000Z","dateModified":"2026-11-16T12:36:57.000Z","language":"en","abstract":"Revenue fell 13% year over year, while net loss narrowed 36% to $12.5 million. The company expects its cash runway to extend into the second quarter of 2028.","section":"Business","references":[]}